Evidence map›Paper›PMID 35979444›Full record

ArticleJournal of multidisciplinary healthcare2022

Time to Recovery of Severely Ill COVID-19 Patients and its Predictors: A Retrospective Cohort Study in Tigray, Ethiopia.

Haftom Temesgen Abebe, Yibrah Berhe Zelelow, Afework Mulugeta Bezabih, Mengistu Mitiku Ashebir, Getachew Redae Tafere, Alem Desta Wuneh, Medhanie Gebresilassie Araya, Nguse Kahsay Kiros, Molla Kahssay Hiluf, Mohamedawel Mohamedniguss Ebrahim and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of multidisciplinary healthcare, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Haftom Temesgen AbebeDepartment of Biostatistics, College of Health Sciences, Mekelle University, Mekelle, Ethiopia.
Yibrah Berhe ZelelowDepartment of Obstetrics and Gynecology, College of Health Sciences, Mekelle University, Mekelle, Ethiopia.
Afework Mulugeta BezabihDepartment of Nutrition, College of Health Sciences, Mekelle University, Mekelle, Ethiopia.
Mengistu Mitiku AshebirDepartment of Health System, College of Health Sciences, Mekelle University, Mekelle, Ethiopia.
Getachew Redae TafereDepartment of Environmental and Behavioral Sciences, College of Health Sciences, Mekelle University, Mekelle, Ethiopia.ORCID 0000-0001-6903-6149
Alem Desta WunehDepartment of Health System, College of Health Sciences, Mekelle University, Mekelle, Ethiopia.ORCID 0000-0003-2497-4494
Medhanie Gebresilassie ArayaDepartment of Ear, Nose and Throat, College of Health Sciences, Mekelle University, Mekelle, Ethiopia.
Nguse Kahsay KirosTigrai Institute of Policy Studies, Mekelle, Ethiopia.
Molla Kahssay HilufDepartment of Public Health, College of Medicine and Health Sciences, Samara University, Samara, Ethiopia.ORCID 0000-0002-6665-6403
Mohamedawel Mohamedniguss EbrahimDepartment of Surgery, College of Health Sciences, Mekelle University, Mekelle, Ethiopia.
Tesfay Gebregzabher GebrehiwotDepartment of Health System, College of Health Sciences, Mekelle University, Mekelle, Ethiopia.ORCID 0000-0002-0535-9368
Abadi Leul WelderufaelDepartment of Pediatric and Child Health, College of Health Sciences, Mekelle University, Mekelle, Ethiopia.
Abrahim Hassen MohammedTigrai Health Bureau, Mekelle, Ethiopia.
Mekelle University · ETSamara University · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: COVID-19 is one of the leading causes of morbidity and mortality and is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). A patient infected with SARS-CoV-2 is said to be recovered from the infection following negative test results and when signs and symptoms disappear. Different studies have shown different median recovery time of patients with COVID-19 and it varies across settings and disease status. This study aimed to assess time to recovery and its predictors among severely ill COVID-19 patients in Tigray. Methods: A total of 139 severely ill COVID-19 patients who were hospitalized between May 7, 2020 and October 28, 2020 were retrospectively analyzed. Cox proportional hazard regression model was fitted to identify the risk factors associated with the time duration to recovery from severe COVID-19 illness. Results: The median age of the patients was 35 years (IQR, 27-60). Eighty-three (59.7%) patients recovered with a median time of 26 days (95% CI: 23-27). The results from the multivariable analysis showed that the recovery time was lower for severely ill patients who had no underline comorbidity diseases (AHR=2.48, 95% CI: 1.18-5.24), shortness of breath (AHR=2.08, 95% CI: 1.07-3.98) and body weakness (AHR=2.62, 95% CI: 1.20-5.72). Moreover, COVID-19 patients aged younger than 40 years had lower recovery time compared to patients aged 60 and above (AHR=4.09, 95% CI: 1.58-10.61). Conclusion: The median recovery time of severely ill COVID-19 patients was long, and older age, comorbidity, shortness of breath, and body weakness were significant factors related with the time to recovery among the severely ill COVID-19 patients. Therefore, we recommended that elders and individuals with at least one comorbidity disease have to get due attention to prevent infection by the virus. Moreover, attention should be given in the treatment practice for individuals who had shortness of breath and body weakness symptoms.

Indexed as

adjusted hazard ratiocomorbidityCOVID-19cox proportional hazard regression

Identifiers

PMID35979444
PMCPMC9377347
OpenAlexW4290988672

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.